IIM
RPRX icon

INTECH Investment Management’s Royalty Pharma RPRX Stock Holding History

INTECH Investment Management’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.52M Buy
44,977
+6,162
+16% +$321K 0.02% 624
2026
Q1 		$1.86M Sell
38,815
-13,512
-26% -$592K 0.02% 736
2025
Q4 		$2.02M Sell
52,327
-919
-2% -$35K 0.02% 731
2025
Q3 		$1.88M Sell
53,246
-117
-0.2% -$4.24K 0.02% 810
2025
Q2 		$1.92M Buy
53,363
+5,371
+11% +$178K 0.02% 783
2025
Q1 		$1.49M Buy
47,992
+13,951
+41% +$442K 0.02% 936
2024
Q4 		$868K Buy
34,041
+21,347
+168% +$566K 0.01% 1236
2024
Q3 		$359K Hold
12,694
– – ﹤0.01% 1408
2024
Q2 		$335K Hold
12,694
– – ﹤0.01% 927
2024
Q1 		$386K Buy
+12,694
New +$374K 0.01% 573
2023
Q3 		– Sell
-18,887
Closed -$581K – 757
2023
Q2 		$581K Buy
18,887
+3,901
+26% +$132K 0.01% 570
2023
Q1 		$540K Sell
14,986
-1,107
-7% -$41K ﹤0.01% 603
2022
Q4 		$636K Buy
16,093
+1,107
+7% +$46.2K ﹤0.01% 582
2022
Q3 		$602K Sell
14,986
-509
-3% -$21.7K ﹤0.01% 568
2022
Q2 		$651K Buy
+15,495
New +$635K ﹤0.01% 579

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

INTECH Investment Management's RPRX Position: Q2 2026 in Review

INTECH Investment Management increased its Royalty Pharma (RPRX) stake by 16% in Q2 2026, buying an estimated $321K and bringing the position to 44,977 shares worth $2.52M. The position accounts for 0.02% of the portfolio, ranked #624.

INTECH Investment Management first reported a position in RPRX in Q2 2022 and has held it in 15 quarters since. 647 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.

  • INTECH Investment Management held 44,977 shares of Royalty Pharma worth $2.52M as of Q2 2026.
  • INTECH Investment Management bought 6,162 Royalty Pharma shares in Q2 2026, an estimated $321K.
  • Royalty Pharma made up 0.02% of INTECH Investment Management's portfolio in Q2 2026, its #624 holding.
  • INTECH Investment Management first reported a position in Royalty Pharma in Q2 2022 and has held it in 15 quarters since.
  • 647 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.

Based on INTECH Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.